by TractManager | Dec 30, 2009 | Emerging Technology Report
An intravenous antibiotic for the treatment of complicated skin and skin structure infections due to gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Dec 21, 2009 | Emerging Technology Report
A fixed-dose, once-weekly, subcutaneously administered anticoagulant for the treatment and secondary prevention of venous thromboembolism in patients with acute symptomatic deep vein thrombosis or pulmonary embolism.If you have a Hayes login, click here to view the...
by TractManager | Dec 10, 2009 | Emerging Technology Report
A gene expression assay performed on excised tumor tissue to improve risk stratification of patients with resected stage II colon cancer.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Dec 9, 2009 | Emerging Technology Report
A subcutaneously administered anti–tumor necrosis factor monoclonal antibody for the second- or third-line treatment of adult patients with moderate-to-severe rheumatoid arthritis. If you have a Hayes login, click here to view the full report on the...
by TractManager | Dec 3, 2009 | Emerging Technology Report
An intravenous antibiotic being developed for the treatment of hospital-acquired pneumonia due to gram-positive bacteria, including ventilator-associated pneumonia.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments